Co-Diagnostics Stock Price, News & Analysis (NASDAQ:CODX)

$2.24 -0.15 (-6.28 %)
(As of 02/22/2018 04:00 PM ET)
Previous Close$2.39
Today's Range$2.20 - $2.39
52-Week Range$2.20 - $6.85
Volume18,499 shs
Average Volume38,456 shs
Market Capitalization$29.36 million
P/E Ratio-4.43
Dividend YieldN/A
BetaN/A

About Co-Diagnostics (NASDAQ:CODX)

Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

Receive CODX News and Ratings via Email

Sign-up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:CODX
CUSIPN/A
Phone+1-801-2789769

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-4.42592592592593
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.54)
Net IncomeN/A
Net Margins-149,750.40%
Return on Equity-3,935.44%
Return on Assets-479.06%

Miscellaneous

EmployeesN/A
Outstanding Shares11,920,000

Co-Diagnostics (NASDAQ:CODX) Frequently Asked Questions

What is Co-Diagnostics' stock symbol?

Co-Diagnostics trades on the NASDAQ under the ticker symbol "CODX."

Who are some of Co-Diagnostics' key competitors?

Who are Co-Diagnostics' key executives?

Co-Diagnostics' management team includes the folowing people:

  • Dwight H. Egan, Chairman of the Board, President, Chief Executive Officer (Age 62)
  • Reed L. Benson, Chief Financial Officer, Secretary (Age 70)
  • Brent Satterfield, Chief Science Officer, Director (Age 40)
  • Edward J. Borkowski CPA, Independent Director (Age 58)
  • Frank J. Kiesner, Independent Director (Age 72)
  • Richard S. Serbin, Independent Director (Age 72)

When did Co-Diagnostics IPO?

(CODX) raised $9 million in an IPO on Thursday, July 13th 2017. The company issued 1,300,000 shares at $6.35-$6.75 per share. WallachBeth Capital and Network 1 Securities acted as the underwriters for the IPO.

When did the company's lock-up period expire?

Co-Diagnostics' lock-up period expired on Monday, January 8th. Co-Diagnostics had issued 1,178,532 shares in its initial public offering on July 12th. The total size of the offering was $7,071,192 based on an initial share price of $6.00. Since the end of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

How do I buy Co-Diagnostics stock?

Shares of Co-Diagnostics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Co-Diagnostics' stock price today?

One share of Co-Diagnostics stock can currently be purchased for approximately $2.24.

How big of a company is Co-Diagnostics?

Co-Diagnostics has a market capitalization of $29.36 million.

How can I contact Co-Diagnostics?

Co-Diagnostics' mailing address is 4049 S Highland Dr, SALT LAKE CITY, UT 84124-1664, United States. The company can be reached via phone at +1-801-2789769.


MarketBeat Community Rating for Co-Diagnostics (CODX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  130
MarketBeat's community ratings are surveys of what our community members think about Co-Diagnostics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Co-Diagnostics (NASDAQ:CODX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Co-Diagnostics (NASDAQ:CODX)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Co-Diagnostics (NASDAQ:CODX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Co-Diagnostics (NASDAQ:CODX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Co-Diagnostics (NASDAQ CODX)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Co-Diagnostics (NASDAQ CODX) News Headlines

Source:
DateHeadline
Co-Diagnostics, Inc. Initiates Vector Control Program in Dominican RepublicCo-Diagnostics, Inc. Initiates Vector Control Program in Dominican Republic
finance.yahoo.com - January 30 at 9:40 AM
Co-Diagnostics Incs Lock-Up Period Will End  on January 8th (NASDAQ:CODX)Co-Diagnostics Inc's Lock-Up Period Will End on January 8th (NASDAQ:CODX)
www.americanbankingnews.com - January 1 at 1:16 AM
Co-Diagnostics, Inc. Announces Sale of Molecular Diagnostic Tests, Including Zika Virus, to Major Caribbean LaboratoryCo-Diagnostics, Inc. Announces Sale of Molecular Diagnostic Tests, Including Zika Virus, to Major Caribbean Laboratory
finance.yahoo.com - December 12 at 9:21 AM
TJR Coatings Inc. Announces the Entering into of a Share Purchase Agreement to Acquire all of the Shares of DNA Logix Canada Inc.TJR Coatings Inc. Announces the Entering into of a Share Purchase Agreement to Acquire all of the Shares of DNA Logix Canada Inc.
www.finanznachrichten.de - November 24 at 4:00 PM
How Does Co-Diagnostics Inc (CODX) Compare To The Healthcare Sector?How Does Co-Diagnostics Inc (CODX) Compare To The Healthcare Sector?
finance.yahoo.com - November 21 at 5:33 PM
Co-Diagnostics, Inc. Reports Q3 Financial Results and Updates Corporate DevelopmentsCo-Diagnostics, Inc. Reports Q3 Financial Results and Updates Corporate Developments
finance.yahoo.com - November 16 at 12:59 PM
Co-Diagnostics, Inc. Products to Be Presented at Fair of Havana 2017Co-Diagnostics, Inc. Products to Be Presented at Fair of Havana 2017
finance.yahoo.com - October 31 at 6:37 PM
Who Owns Co-Diagnostics Inc (CODX)?Who Owns Co-Diagnostics Inc (CODX)?
finance.yahoo.com - October 20 at 6:51 PM
Co-Diagnostics, Inc. to Present Zika Tests to Dominican Republic Ministry of HealthCo-Diagnostics, Inc. to Present Zika Tests to Dominican Republic Ministry of Health
finance.yahoo.com - October 16 at 6:10 PM
Co-Diagnostics, Inc. to Present at NewsMakers Conference 2017Co-Diagnostics, Inc. to Present at NewsMakers Conference 2017
finance.yahoo.com - September 7 at 5:28 PM
Co-Diagnostics (CODX) to Sign Purchase Agreement with MEDCIS PathlabsCo-Diagnostics (CODX) to Sign Purchase Agreement with MEDCIS Pathlabs
www.streetinsider.com - September 6 at 5:25 PM
Co-Diagnostics, Inc. to Sign Purchase Agreement with MEDCIS PathlabsCo-Diagnostics, Inc. to Sign Purchase Agreement with MEDCIS Pathlabs
finance.yahoo.com - September 5 at 6:59 PM
Co-Diagnostics, Inc. (CODX)Co-Diagnostics, Inc. (CODX)
finance.yahoo.com - August 27 at 9:51 PM
Co-Diagnostics, Inc. Strengthens Zika Customer Base in Caribbean BasinCo-Diagnostics, Inc. Strengthens Zika Customer Base in Caribbean Basin
finance.yahoo.com - August 24 at 5:32 PM
Co-Diagnostics, Inc. CEO to Present at 2017 SALSSCo-Diagnostics, Inc. CEO to Present at 2017 SALSS
finance.yahoo.com - August 22 at 11:02 PM
Co-Diagnostics Incs (CODX) Quiet Period Set To End  on August 21stCo-Diagnostics Inc's (CODX) Quiet Period Set To End on August 21st
www.americanbankingnews.com - August 14 at 1:20 AM
Co-Diagnostics, Inc. to Undergo ISO 13485:2016 AuditCo-Diagnostics, Inc. to Undergo ISO 13485:2016 Audit
finance.yahoo.com - August 10 at 6:41 PM
Co-Diagnostics, Inc. to Attend AACC 2017Co-Diagnostics, Inc. to Attend AACC 2017
finance.yahoo.com - August 2 at 6:12 PM
Co-Diagnostics, Inc. Announces Joint Venture in IndiaCo-Diagnostics, Inc. Announces Joint Venture in India
finance.yahoo.com - August 1 at 12:23 PM
Co-Diagnostics, Inc. Verifies Zika CoPrimer™ TestCo-Diagnostics, Inc. Verifies Zika CoPrimer™ Test
finance.yahoo.com - August 1 at 12:23 PM
Co-Diagnostics (NASDAQ:CODX) to Raise $9 Million in IPOCo-Diagnostics (NASDAQ:CODX) to Raise $9 Million in IPO
www.americanbankingnews.com - July 8 at 10:20 AM

SEC Filings

Co-Diagnostics (NASDAQ:CODX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Co-Diagnostics (NASDAQ:CODX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Co-Diagnostics (NASDAQ CODX) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.